🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carin R. Espenschied

Guardant (United States)

ORCID: 0000-0001-6108-7785

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Duration of Targeted Therapy in Patients With Advanced Non–small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis”.

Duration of Targeted Therapy in Patients With Advanced Non–small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.06.015

N/A

0DataRank · unranked

13 citations

Tejas Patil, Kedar Kirtane, Thereasa A. Rich, Carin R. Espenschied, Caroline Weipert +5 more

Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0151

N/A

0DataRank · unranked

8 citations

Zoe Quandt, Sara Wienke, Jing Wang, Sean Gordon, Reagan M. Barnett +8 more

Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies

The Journal of Liquid Biopsy(2025)10.1016/j.jlb.2025.100442

N/A

0DataRank · unranked

2 citations

Moh’d Khushman, Alessandro Russo, Roberto Borea, Bernard Herrman, Jing Wang +7 more